SCHEMBL306278

SCHEMBL306278

CCNc1ccccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394898 1.00
Hydrochloric Acid SCHEMBL14743180 0.98 CXCR4 (0.59)
SCHEMBL27534576 0.98 CXCR4 (0.59)
SCHEMBL27341991 0.83 CXCR4 (0.45)
SCHEMBL327850 0.83 CYP2C19 (0.65)
SCHEMBL31015708 0.83 CYP2C19 (0.65)
SCHEMBL3265804 0.81 CYP1A2 (0.70)
Hydrochloric Acid SCHEMBL17871621 0.81 CYP2C19 (0.62)
Hydrochloric Acid SCHEMBL27761585 0.81 CYP2C19 (0.62)
SCHEMBL27342593 0.80 CXCR4 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 984 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673146-A2 METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS Biohaven Therapeutics Ltd. (VG) 2026-01-07 EP claimed
US-12251478-B2 Bioactive polymeric dressing for accelerated wound closure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-03-18 US claimed
US-20240425446-A1 DICHLOROMETHANE-FREE SYNTHESIS OF CYCLOPROPENIMINES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2024-12-26 US claimed
WO-2024182465-A2 METHODS FOR TREATING OBSESSIVE COMPULSIVE RELATED DISORDERS, TIC DISORDERS AND GLUTAMATE EXCITOTOXICITY RELATED DISORDERS ALCO THERAPEUTICS, LLC (US) 2024-09-06 WO claimed
US-20240261459-A1 BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-08-08 US claimed
US-11896724-B2 Bioactive polymeric dressing for accelerated wound closure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-02-13 US claimed
CN-110862416-B Metal ruthenium complex ratiometric luminescent probe, preparation thereof and application thereof in real-time detection of amyloid protein fibrosis process 华侨大学 2022-10-14 CN claimed
CN-114045009-B Liquid crystal polymer film and film antenna made of same 浙江甬川聚嘉新材料科技有限公司 2022-09-20 CN claimed
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US claimed
EP-3558944-B1 HYDROGENATION OF A SUBSTITUTED 2-METHYL CYANOPYRIDYL DERIVATIVE IN THE PRESENCE OF A RANEY COBALT CATALYST BAYER CROPSCIENCE AG (DE) 2022-03-09 EP claimed
JP-2002506029-A 2002-02-26 JP claimed
US-20010039292-A1 Lipoic acid analogs THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION 2001-11-08 US claimed
EP-1061914-A1 LIPOIC ACID ANALOGS REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-12-27 EP claimed
US-6090842-A REDUCES CONCENTRATION OF OXYGEN IN CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-07-18 US claimed
WO-1999045922-A1 LIPOIC ACID ANALOGS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-09-16 WO claimed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US claimed
CN-1151735-A Benzocycloalkylazolethione derivatives SYNTEX INC (US) 1997-06-11 CN claimed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP claimed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO claimed
US-4474876-A Flow cytometric analysis of histamine receptors TRUSTEES OF BOSTON UNIVERSITY (US) 1984-10-02 US claimed